e-learning
resources
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD is associated with an increased risk of peripheral artery disease and mortality
Natalie Terzikhan, Lies Lahousse, Katia M.C. Verhamme, Oscar H. Franco, M. Arfan Ikram, Bruno H. Stricker, Guy G. Brusselle
Source:
ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Natalie Terzikhan, Lies Lahousse, Katia M.C. Verhamme, Oscar H. Franco, M. Arfan Ikram, Bruno H. Stricker, Guy G. Brusselle. COPD is associated with an increased risk of peripheral artery disease and mortality. ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
COPD phenotypes not linked to increased risk of coronary heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019
Increased risk of peripheral arterial disease in individuals with COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Prevalence and risk factors of elevated pulmonary artery pressures in adults with sickle cell disease
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009
The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011
Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene
Source: Eur Respir J, 55 (2) 1901812; 10.1183/13993003.01812-2019
Year: 2020
Coronary artery calcification in COPD is associated with adverse functional assessments and mortality
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Elevated pulmonary vascular resistance predicts mortality in COPD patients
Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Year: 2021
Neutrophils and the increased risk of cardiovascular events in severe COPD
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
Arterial hypertension and the risk of severity and mortality of COVID-19
Source: Eur Respir J, 55 (6) 2001148; 10.1183/13993003.01148-2020
Year: 2020
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept